Stepping back from the day-to-day volatility, the bottom line is that interest rates are going to move lower, said Chicago Fed President Austan Goolsbee, on Friday. "As long as we keep making progress ...

The cost of imported goods snapped back in October and added a bit more upward pressure to U.S. inflation, largely because of ...

Sales at retailers rose solidly in October and suggested the economy still has plenty of momentum heading into the holiday ...

The numbers: The New York Fed’s Empire State business conditions index, a gauge of manufacturing activity in the state, ...

InflaRx shares rose 12% in premarket trading after regulators issued a positive opinion recommending marketing authorization of Gohibic. Shares on Friday were trading around $2.27. The stock is up 25% ...

Hundreds of hotel workers at a casino near the Las Vegas Strip went on strike just before dawn Friday after a long and highly ...

“The Later Daters” brings six divorcees and widowers back to the dating pool with the help of family members and a ...

Shares of Akoya Biosciences tumbled after the company cut its full-year revenue outlook and said it was considering strategic alternatives. The stock was down 21% at $2.46 in premarket trading. Shares ...

Thermo Fisher Scientific's board has approved a new $4 billion stock buyback program. The Waltham, Mass., Life-sciences giant on Friday said the new program has no expiration date and replaces its ...

Calavo Growers named James Snyder as its next chief financial officer after CFO Shawn Munsell departs the company. The Santa Paula, Calif., avocado and fruit grower said Friday that Munsell, after ...

NEW YORK — The decline in U.S. drug-overdose deaths appears to have continued this year, giving experts hope the nation is ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...